17
May
Depression In Hiv Infected Patients A Review. Accurately diagnosing major depressive disorder in the context of HIV is an ongoing challenge to clinicians and researchers being complicated by the complex biological psychological and social factors associated with the HIV illness. For example studies which rely on medical record. Depression is the most common neuropsychiatric complication in HIV-infected patients and may occur in all phases of the infection. 1112 In PLWHA contributory factors for depression include comorbidities coping with the prospects of illness and death neurobiological changes related to persistent central nervous system CNS infections due to HIV social stigma sexual dysfunction and side effects of ART.
By analyzing the most relevant studies MEDLINE EMBASE PsycLit Cochrane Library the review. A great deal of time and money are spent on controlling and reducing the complications of this infection across the world. A recent review indicates that the point prevalence of depression in the general Korean population ranges from 76 to 169 and increases with age. 1112 In PLWHA contributory factors for depression include comorbidities coping with the prospects of illness and death neurobiological changes related to persistent central nervous system CNS infections due to HIV social stigma sexual dysfunction and side effects of ART. Another cohort study among pregnant women in Tanzania showed depressive symptoms among HIV-infected women were associated with a significantly increased risk of clinical disease progression to WHO HIVAIDS clinical stages III and IV 29. Depression in HIV Infected Patients.
A recent review indicates that the point prevalence of depression in the general Korean population ranges from 76 to 169 and increases with age.
Depression and mortality in the HIV context. A recent review indicates that the point prevalence of depression in the general Korean population ranges from 76 to 169 and increases with age. Depression has long been recognized as a predictor of negative clinical outcomes in HIV-infected patients such as reducing medication adherence quality of life and treatment outcome and possibly worsening the progression of the illness and increasing mortality. For example among 1487 women followed for 24 months in Tanzania mortality was 66 among women with depressive symptoms versus 37 among women without depressive symptoms 66. In this study the prevalence of depression in HIV-infected patients was 21 comparable to previous reports for HIV-infected patients which observed prevalence typically ranging from 20 to 36. Major depression is a substantial burden to HIV-positive patients and the mental health needs of these patients are frequently unmet.